OBJECTIVE: To present a summary of the 2013 version of the European Association of
Urology guidelines on the treatment and follow-up of male lower urinary tract symptoms …

Context Lower urinary tract symptoms (LUTS) are common, often bothersome, and have
multifactorial aetiology. Objective To present a summary of the 2023 version of the European …

Current Treatment for Benign Prostatic Hyperplasia - PMC Back to Top Skip to main content NIH
NLM Logo Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation …

Benign prostatic hyperplasia (BPH), which causes lower urinary tract symptoms (LUTS), is a
common diagnosis among the ageing male population with increasing prevalence. Many …

Introduction The normal bladder functions, storage and elimination of urine, are based on a
coordinated interplay of reciprocal contraction and relaxation of the bladder and the outflow …

The discovery of the nitric oxide/cGMP pathway was the basis for our understanding of many
normal physiological functions and the pathophysiology of several diseases. Since the …

This overview represents the updated recommendations for diagnosis and management of
non-neurogenic male lower urinary tract symptoms (LUTS) due to benign prostatic …

Context Androgen modulation of erectile function (EF) is widely accepted. However, the use
of testosterone replacement therapy (TRT) in men with erectile dysfunction (ED) has …

Orthostatic hypotension (OH) is an abnormal blood pressure response to standing, which is
associated with an increased risk of adverse outcomes such as syncope, falls, cognitive …

Benign prostatic hyperplasia (BPH) is the most common benign disease of the prostate
gland and is caused by benign hyperplasia of the smooth muscle cells and stromal cells in …